Mary-Claire King reflects on BRCA1 discovery and Nobel speculation
In a conversation with STAT News, geneticist Mary-Claire King discusses her landmark identification of the BRCA cancer mutations and what it is like to be a perennial Nobel contender.
STAT News has published a profile interview with Mary-Claire King, the University of Washington geneticist who in 1990 identified that a single gene — later named BRCA1 — accounts for a substantial proportion of hereditary breast and ovarian cancers in affected families. The piece, timed to coincide with this year's Nobel Prize season announcements, explores King's experience of being frequently named in prize predictions without yet receiving the call from the Nobel Committee.
King describes the particular psychological texture of the October announcement period for researchers whose work is regularly cited in Nobel commentary. The conversation also touches on her broader scientific contributions, including the use of mitochondrial DNA analysis to identify victims of enforced disappearance in Argentina — work that demonstrated early applications of forensic genetics.
The item is a feature profile rather than a report on new research. It is editorially relevant to Genetic Current because King's identification of hereditary breast and ovarian cancer susceptibility remains foundational to clinical and research genetics, and because the conversation illustrates the trajectory from basic linkage mapping to clinical application that defines much of modern medical genetics. No new findings are reported.
Plain-language version
For patients, families, and general readers. Educational only — not medical advice.
Mary-Claire King is a geneticist who, in 1990, discovered that faults in a single gene — later called BRCA1 — can run in families and significantly increase the chance of developing breast or ovarian cancer. This discovery changed how doctors think about inherited cancer risk and led to genetic tests now used worldwide.
A new interview with King, published by STAT News, discusses what it is like to be frequently mentioned as a potential Nobel Prize winner. She also describes her work helping identify victims of enforced disappearance in Argentina using DNA analysis.
No new research findings are announced in this interview. It is a personal and historical account of one scientist's career.
This is an educational summary, not medical advice. If anything here raises questions for you, please speak with your GP or a clinical professional.
Sources
Read the original reporting — these are the public sources this summary draws from.
-
Primary source Stat News · 2026-10-02What it's like to wait for the call from the Nobel Prize committee